54 results
Page 3 of 3
8-K
EX-99.1
njhk5lf2o 6gp
9 May 19
G1 Therapeutics Provides First Quarter 2019 Corporate and Financial Update
4:26pm
8-K
EX-99.1
8c33suv6cz 9jg8lezsn
29 Apr 19
G1 Therapeutics Announces Positive Feedback from TrilaciclibEnd-of-Phase 2
4:07pm
8-K
EX-99.1
47sy2
28 Feb 19
G1 Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results
4:08pm
424B5
p6a20a4 2z13h5
19 Sep 18
Prospectus supplement for primary offering
4:58pm
S-3ASR
5d3s7hsg7nw t01swzey
15 Jun 18
Automatic shelf registration
5:02pm
10-K
bkj8sw8r rk
21 Feb 18
Annual report
12:00am
10-Q
nlzxuu4q
9 Aug 17
Quarterly report
12:00am
8-K
EX-99.1
uqlxzja9
14 Jul 17
G1 Therapeutics Appoints Sir Andrew Witty to Board of Directors
12:00am